Amalgamated Financial’s Agilon Health AGL Stock Holding History

Amalgamated Financial’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$968K	Buy	+1,528	New	+$788K	0.01%	1187

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Amalgamated Financial's AGL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Agilon Health (AGL) in Q1 2022: 1,528 shares worth $968K. The stake represents 0.01% of the portfolio and ranks #1187 among its holdings.

121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

Amalgamated Financial held 1,528 shares of Agilon Health worth $968K as of Q1 2022.
Agilon Health was a new Amalgamated Financial position in Q1 2022.
Agilon Health made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1187 holding.
121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.